Mechanisms of disease: the pathogenesis of pituitary tumors

被引:69
作者
Ezzat, S
Asa, SL
机构
[1] Mt Sinai Hosp, Freeman Ctr Endocrine Oncol, Toronto, ON M5G 1X5, Canada
[2] Univ Toronto, Dept Med, Princess Margaret Hosp, Toronto, ON, Canada
[3] Univ Hlth Network, Dept Pathol, Toronto, ON M5G 2C4, Canada
[4] Toronto Med Labs, Toronto, ON, Canada
[5] Ontario Canc Inst, Toronto, ON M4X 1K9, Canada
来源
NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM | 2006年 / 2卷 / 04期
关键词
growth factors; oncogenes; pituitary; tumor-suppressor genes; tumors;
D O I
10.1038/ncpendmet0159
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Pituitary tumors exhibit a spectrum of biology, with variable growth and hormonal behaviors. They therefore provide an opportunity to examine pathogenetic mechanisms that underlie the neoplastic process. These include alterations in hormone regulation, growth-factor stimulation, cell-cycle control and cell-stromal interactions that result from genetic mutations or epigenetic disruption of gene expression. Mouse models have validated the roles of these alterations, which can be targets for the development of therapies that can manage these lesions. These therapies are increasingly recognized as critical for quality of life.
引用
收藏
页码:220 / 230
页数:11
相关论文
共 75 条
  • [71] A novel transcript for the thyrotropin-releasing hormone receptor in human pituitary and pituitary tumors
    Yamada, M
    Hashimoto, K
    Satoh, T
    Shibusawa, N
    Kohga, H
    Ozawa, Y
    Yamada, S
    Mori, N
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (12) : 4224 - 4228
  • [72] Pituitary tumor AP-2α recognizes a cryptic promoter in intron 4 of fibroblast growth factor receptor 4
    Yu, SJ
    Asa, SL
    Weigel, RJ
    Ezzat, S
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (22) : 19597 - 19602
  • [73] Loss of expression of GADD45γ, a growth inhibitory gene, in human pituitary adenomas:: Implications for tumorigenesis
    Zhang, X
    Sun, HP
    Danila, DC
    Johnson, SR
    Zhou, YL
    Swearingen, B
    Klibanski, A
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (03) : 1262 - 1267
  • [74] Hypermethylation of the promoter region is associated with the loss of MEG3 gene expression in human pituitary tumors
    Zhao, J
    Dahle, D
    Zhou, YL
    Zhang, X
    Klibanski, A
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (04) : 2179 - 2186
  • [75] Truncated activin type I receptor Alk4 isoforms are dominant negative receptors inhibiting activin signaling
    Zhou, YL
    Sun, HP
    Danila, DC
    Johnson, SR
    Sigai, DP
    Zhang, X
    Klibanski, A
    [J]. MOLECULAR ENDOCRINOLOGY, 2000, 14 (12) : 2066 - 2075